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We read with interest the recent article by
Manser et al.1 regarding the incidental lung cancers
identified as coronial autopsy. We agree with their
conclusion that there are some lung cancers that
remain undetected during life and do not contri-
bute to death. However, we cannot completely
accept their hypothesis that some lung cancers
detected by screening may never progress to cause
symptoms or death in that individual’s lifetime and
therefore may be overdiagnosed by screening. Of
the 28 invasive non-small cell lung cancer in their
study, 24(86%) were stage I and only two were stage
III–IV.1 In 52 of 107 individuals that died naturally,
the authors assessed lung cancer did not contribute
to death.1 With regard to lung cancers detected by
mass screening and those detected incidentally, we
previously studied characteristics and outcomes of
the patients.2–4 In our studies, 39(47%) of 83
cancers detected by annual chest X-ray mass
screening, and 52(30%) of 173 cancers detected
incidentally were stage I disease, respectively.3,4
Seventeen(20%) cancers detected by the mass
screening were stage IV,3 and 83(48%) cancers
detected incidentally were stage IIIB–IV diseases.4
Although the survivals of mass-screened patients
and incidentally diagnosed patients were signifi-
cantly better than that of the symptomatic
patients, lung cancer patients, especially advanced
staged ones, died from the disease during the study
periods.2,4 These differences in staging and out-
come between the study by Manser et al. and ours
may largely depend on the difference in study
method and population evaluated. However, the
hypothesis by Manser et al. may not be applicable
to all the lung cancer patients detected by massee front matter & 2004 Elsevier Ltd. All rights reserv
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nal article 10.1016/j.rmed.2004.08.017screening and those detected incidentally. At
present, we suppose that this hypothesis may be
indicated only for small-sized lung adenocarcinoma
with the appearance of a ground glass attenuation
detected by CT screening.5 We appreciate hearing
from the authors comment on these differences in
staging and outcome. In addition, we would like to
know whether the hypothesis of authors’ would be
applicable to all the lung cancer patients detected
by mass screening and those detected incidentally.References
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